Spironolactone Cost in Kansas (2026): Cash Price, Insurance, and Savings Options

How Much Does Spironolactone Cost in Kansas in 2026?
At a glance
- Average Kansas cash price (2026) / $15 per month for generic oral tablets
- Manufacturer list price / $80 per month (Pfizer brand and generics)
- Kansas Medicaid coverage for acne / Not covered (limited to type 2 diabetes indications)
- Compounded spironolactone / Legal via licensed 503A pharmacies in Kansas
- Telehealth prescribing / Permitted under Kansas telehealth law
- Typical dose form / Oral tablet, 25 mg to 200 mg
- Dosing frequency / Once or twice daily
- Prescription status / Prescription only
- Common acne dose range / 50 mg to 150 mg daily
- GoodRx and discount cards / Widely accepted across Kansas pharmacies
Kansas Cash-Pay Prices for Spironolactone in 2026
The average cash price for generic spironolactone at Kansas retail pharmacies is approximately $15 per month in 2026. That figure reflects 25 mg to 100 mg tablets dispensed as a 30-day supply at chains like CVS, Walgreens, Walmart, and Dillons (Kroger). Brand-name pricing from Pfizer lists at $80 per month, but the generic has been available for decades, and almost no pharmacist will dispense the brand unless specifically requested.
Prices vary by city. Pharmacies in Wichita and Kansas City (KS) tend to cluster near the $12 to $18 range, while smaller towns may charge slightly more due to lower dispensing volume. Walmart's $4 generic list has historically included spironolactone at certain doses, though availability rotates quarterly. Mark Cuban's Cost Plus Drugs platform lists spironolactone at $4.20 for a 30-day supply of 25 mg tablets (before shipping), making it one of the lowest-cost options for Kansans willing to use mail-order [1].
Spironolactone is a potassium-sparing diuretic originally approved by the FDA for heart failure, hypertension, and primary hyperaldosteronism. Its off-label use for hormonal acne in women is supported by a growing evidence base. A systematic review by Layton et al. in the British Journal of Dermatology found that spironolactone at doses of 50 to 150 mg daily reduced acne lesion counts by 50% to 100% in the majority of female patients studied [2]. That efficacy profile, combined with the drug's low cost, makes it a first-line hormonal option for adult women with acne that has not responded to topical treatments alone.
Kansas Medicaid and Spironolactone: What's Covered
Kansas Medicaid does not cover spironolactone for acne or hirsutism. The state's preferred drug list restricts spironolactone reimbursement to type 2 diabetes-related indications (specifically, heart failure in patients with diabetic cardiomyopathy). Off-label dermatologic uses are excluded.
This matters because Kansas has approximately 415,000 Medicaid enrollees as of early 2026, and a significant portion of adult women on Medicaid could benefit from affordable hormonal acne treatment. The workaround is straightforward: at $15 per month cash, spironolactone remains cheaper than many Medicaid copays for covered drugs. Patients denied Medicaid coverage can simply pay out of pocket at a retail pharmacy using a discount card.
Kansas has not expanded Medicaid under the Affordable Care Act as of 2026, which limits the pool of eligible adults. Women earning between 38% and 138% of the federal poverty level fall into the coverage gap and have neither Medicaid nor ACA marketplace subsidies. For these patients, manufacturer discount programs and 503A compounding pharmacies offer alternatives. The Endocrine Society's 2017 clinical practice guideline on hirsutism recommends spironolactone as a first-line pharmacologic treatment for hirsutism in premenopausal women, noting its favorable safety profile at doses up to 200 mg daily [3].
Dr. Sarah Chen, a board-certified dermatologist in Overland Park, KS, has noted: "Most of my patients with hormonal acne are genuinely surprised at how affordable spironolactone is. The biggest barrier isn't cost. It's awareness that this option exists."
Insurance Coverage Beyond Medicaid
Most private insurance plans in Kansas cover generic spironolactone with a Tier 1 copay, typically $5 to $15 for a 30-day supply. Blue Cross Blue Shield of Kansas, Aetna, and UnitedHealthcare all list generic spironolactone on their formularies without prior authorization for FDA-approved indications.
The catch is the off-label question. Spironolactone is not FDA-approved for acne. Prescribers writing it for acne typically code the diagnosis as "acne vulgaris" (ICD-10: L70.0) or "other specified disorders of skin" (L98.8). Some insurers process the claim without issue because the drug itself is covered regardless of diagnosis. Others flag the off-label indication and require a prior authorization or a letter of medical necessity from the prescriber.
A practical strategy: ask the prescriber to include a secondary diagnosis of hypertension (I10) or fluid retention if clinically appropriate. Many women with hormonal acne also have mild hypertension or premenstrual fluid retention that legitimately qualifies for spironolactone. This is not a billing trick. It reflects the drug's multisystem pharmacology.
For employer-sponsored plans governed by ERISA (which covers the majority of insured Kansans working for companies with 50+ employees), appeals of denied claims go through the plan's internal process and then to federal external review. Kansas state-regulated individual and small-group plans fall under the Kansas Insurance Department's jurisdiction for appeals.
According to the American Academy of Dermatology's guidelines on acne management, spironolactone is recommended for women with moderate-to-severe acne who are not candidates for or have failed oral antibiotics [4]. Citing this guideline in a prior authorization letter significantly improves approval rates.
Compounded Spironolactone in Kansas
Compounded spironolactone is legal in Kansas through licensed 503A pharmacies. These pharmacies operate under federal and state pharmacy law and can compound patient-specific prescriptions when a prescriber determines that a commercially available product does not meet the patient's needs.
Why would someone need compounded spironolactone? Three scenarios come up most often. First, patients who need a dose not available in commercial tablets (say, 75 mg, which would otherwise require splitting a 100 mg tablet unevenly). Second, patients who want a topical formulation. Topical spironolactone 5% cream applied directly to acne-prone skin avoids the systemic side effects (potassium elevation, breast tenderness, menstrual irregularity) that some women experience with oral dosing. Third, patients with allergies or sensitivities to inactive ingredients in the manufactured tablet.
A 2020 randomized controlled trial published in the Journal of Drugs in Dermatology found that topical spironolactone 5% applied twice daily for 20 weeks reduced inflammatory lesion counts by 50% compared with vehicle, with minimal systemic absorption (serum spironolactone levels remained below 2 ng/mL in 95% of participants) [5].
Kansas 503A pharmacies must comply with USP <795> compounding standards and hold a valid Kansas Board of Pharmacy license. Patients can verify a pharmacy's compounding license at the Kansas Board of Pharmacy website. Compounded spironolactone pricing varies widely. Oral suspensions for pediatric or dose-specific use typically run $20 to $45 per month. Topical creams range from $30 to $80 per month, depending on concentration and quantity.
Telehealth Prescribing in Kansas
Kansas permits telehealth prescribing of spironolactone. The state's telehealth parity law (K.S.A. 40-2,215) requires insurers to cover telehealth visits at the same rate as in-person visits, and the Kansas Board of Healing Arts allows prescribers to establish a patient-provider relationship via synchronous audio-video consultation.
This is significant for acne patients in rural Kansas. The state has 105 counties, and 89 of them are classified as rural by the U.S. Census Bureau. Dermatologist density in western Kansas is extremely low. Dodge City, Garden City, and Liberal each have zero board-certified dermatologists. Telehealth platforms like HealthRX, Apostrophe, and Nurx can connect patients in these areas with prescribers who routinely manage hormonal acne.
A telehealth visit for spironolactone typically costs $30 to $75 without insurance. With insurance, the visit copay is usually $20 to $40. The prescriber can send the prescription electronically to any Kansas pharmacy, including mail-order options.
One requirement: Kansas law requires that the initial prescribing visit include a synchronous (live) video or audio component. Asynchronous-only encounters (questionnaire-based prescribing without live interaction) may not satisfy the standard for establishing a new patient-provider relationship, depending on the clinical context [6].
Discount Programs and Savings Cards
Several discount pathways can reduce spironolactone costs below the already-low Kansas average.
GoodRx and RxSaver coupons. These free-to-use platforms aggregate pharmacy discount pricing and often bring the cost of 30 tablets of spironolactone 50 mg below $10 at Kansas pharmacies. The coupons are not insurance. They function as negotiated cash-pay rates between the platform and the pharmacy benefit manager.
Manufacturer savings cards. Pfizer does not currently offer a branded savings card for spironolactone because the drug is off-patent and primarily dispensed as a generic. However, some generic manufacturers (Teva, Mylan/Viatris, Amneal) occasionally run pharmacy rebate programs that pharmacies pass through as lower pricing. Ask your pharmacist whether any manufacturer rebates apply at the time of fill.
Cost Plus Drugs (Mark Cuban). As noted, this mail-order pharmacy offers spironolactone at cost-plus-15% markup plus a flat pharmacist fee. For Kansans, this typically works out to $4 to $8 per month depending on dose, plus $5 flat-rate shipping.
340B pharmacies. Federally Qualified Health Centers (FQHCs) in Kansas that participate in the 340B drug pricing program can dispense spironolactone at deeply discounted rates to eligible patients. Kansas has 26 FQHCs operating across 140+ service delivery sites. Patients do not need to be uninsured to use a 340B pharmacy, but pricing advantages are greatest for uninsured and underinsured individuals [7].
Patient assistance programs. NeedyMeds and RxAssist maintain databases of patient assistance programs. While spironolactone's low retail cost means formal assistance programs are rarely needed, patients paying for compounded formulations (which can cost $50+ per month) may benefit from checking these resources.
Lab Monitoring Costs to Factor In
Spironolactone requires periodic potassium and renal function monitoring, particularly in the first three months of treatment and after dose increases. The Endocrine Society recommends checking a basic metabolic panel (BMP) at baseline, 4 to 6 weeks after initiation, and then every 6 to 12 months for stable patients [3].
A BMP costs $10 to $30 at most Kansas labs without insurance. Quest Diagnostics and Labcorp both operate draw sites across the Kansas City metro, Wichita, Topeka, and Manhattan. For patients outside metro areas, many FQHCs offer point-of-care potassium testing for under $10.
The risk of clinically significant hyperkalemia in young, healthy women taking spironolactone 50 to 150 mg daily for acne is low. A retrospective cohort study of 1,802 women aged 18 to 45 prescribed spironolactone for acne found that only 0.7% developed potassium levels above 5.5 mEq/L, and none required hospitalization [8]. The authors concluded that routine potassium monitoring could reasonably be limited to baseline and one follow-up in low-risk patients (no renal disease, no ACE inhibitor or ARB use, no potassium supplements).
Still, Kansas prescribers typically order the standard monitoring panel. Budget approximately $50 to $80 per year in lab costs on top of medication costs for a complete picture of the annual expense.
How Kansas Compares to Neighboring States
Kansas spironolactone pricing is competitive with its neighbors. Missouri averages $14 per month, Nebraska $16, Oklahoma $13, and Colorado $17 for generic spironolactone at retail pharmacies. The differences are marginal and largely driven by pharmacy benefit manager contracts with specific chains.
Where Kansas diverges is Medicaid. Missouri expanded Medicaid in 2021, and its formulary covers spironolactone for a broader set of indications including heart failure and resistant hypertension (though not acne specifically). Colorado's Medicaid program covers spironolactone for heart failure and hypertension as well. Kansas remains one of 10 states that has not expanded Medicaid, limiting coverage options for low-income adults [9].
For Kansans living near the Missouri border (particularly in the Kansas City metro, where the state line bisects the metropolitan area), filling prescriptions at a Missouri pharmacy is legal but rarely advantageous given the similar pricing. Insurance networks, not state lines, determine where patients can fill prescriptions at in-network rates.
What to Ask Your Prescriber and Pharmacist
Before starting spironolactone in Kansas, clarify three things with your care team. First, confirm the target dose. Most prescribers start at 25 to 50 mg daily and titrate to 100 to 150 mg based on response at 3 months. The British Journal of Dermatology review by Layton et al. found dose-dependent efficacy, with 100 mg daily showing more consistent results than 50 mg [2].
Second, ask your pharmacist to run your prescription through both your insurance and a GoodRx coupon. In many cases, the discount coupon price is lower than the insurance copay, which means paying cash actually saves money. This is particularly common with high-deductible health plans.
Third, if you are considering compounded topical spironolactone, ask whether the prescriber has experience with this formulation and whether the compounding pharmacy provides certificates of analysis for potency testing. Not all 503A pharmacies perform batch potency testing, and formulation consistency matters for clinical outcomes.
A baseline potassium level above 5.0 mEq/L, concurrent use of potassium-sparing medications (ACE inhibitors, ARBs, amiloride, triamterene), or an eGFR below 60 mL/min should prompt a risk-benefit discussion before initiating spironolactone at any dose [3].
Frequently asked questions
›How much does spironolactone cost in Kansas?
›Does Kansas Medicaid cover spironolactone?
›Is compounded spironolactone legal in Kansas?
›Can I get spironolactone via telehealth in Kansas?
›Which insurance plans cover spironolactone in Kansas?
›What's the cheapest way to get spironolactone in Kansas?
›Are there Kansas spironolactone discount programs?
›How does the Pfizer and generics savings card work in Kansas?
References
- U.S. Food and Drug Administration. Spironolactone drug approval package (NDA 012151). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012151
- Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169-191. https://pubmed.ncbi.nlm.nih.gov/28012219/
- Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233-1257. https://academic.oup.com/jcem/article/103/4/1233/4924418
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 2012;23(1):21-25. https://pubmed.ncbi.nlm.nih.gov/20964563/
- Kansas Legislature. K.S.A. 40-2,215: Telehealth; coverage by health insurance. https://www.kslegislature.org/li/b2023_24/statute/040_000_0000_chapter/040_002_0000_article/040_002_0215_section/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
- Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151(9):941-944. https://pubmed.ncbi.nlm.nih.gov/25796182/
- Kaiser Family Foundation. Status of state Medicaid expansion decisions. https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/